Tesamorelin is a synthetic peptide that mimics the growth hormone-releasing hormone (GHRH), which stimulates the release of growth hormone. It is primarily used to reduce abdominal fat in individuals with HIV-associated lipodystrophy, a condition that causes abnormal fat distribution. Tesamorelin is typically administered through subcutaneous injection.
The Tesamorelin 2mg (10 Vial Kit) typically contains 10 vials, each with 2mg of Tesamorelin peptide. This kit is commonly used for individuals who need a more extended course of treatment. When preparing for injection, Tesamorelin needs to be reconstituted with a sterile diluent, usually bacteriostatic water, before administration.